← Leaderboards
Laura M. De Castro
Duke University
$916,534
Attributed
$1,124,649
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $358.7K · FY2008–11$500K$375K$250K$125K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$812,173 · 2
AHRQ$312,476 · 1
By mechanism
R21$728,707 · 2
K01$395,942 · 1
Top collaborators
- Marilyn J Telen2 shared
Most similar at Duke University
Same institution · by research overlap
- Marilyn J Telen$25,715,109
- Timothy J McMahon$5,782,284
- Michael Barry Kastan$65,974,699
- Ann Marie Pendergast$20,201,860
- Thomas F Tedder$11,276,163
Others in their field
Top investigators on “Epinephrine”
- Vanessa Sperandio · University Of Wisconsin-Madison$16,424,155
- Krystof S Bankiewicz · Ohio State University$15,083,251
- Robert A Wood · Johns Hopkins University$9,574,867
- Ruchi S Gupta · Northwestern University At Chicago$9,362,742
- Brian K Kobilka · Stanford University$8,914,083
- Brian K. Shoichet · Univ Of North Carolina Chapel Hill$7,131,726
Research focus
EpinephrineGenetic PolymorphismEffectivenessEndothelial CellsErythrocytesGenesAdhesivesDisabilityAdhesion ReceptorDrug EfficacyAdrenergic ReceptorBlood PressureAdhesionsFda ApprovedChronicAnimal ModelClinical EffectivenessBaseClinical ResearchClinical TrialsAdenylate CyclaseDoseDesignGenotype
Grant awards (7)
PROPRANOLOL AS ANTI-ADHESIVE THERAPY IN SCD$223,681
R21 · FY2011 · HL
Phase 11 Study of Propranolol as Anti-Adhesive Therapy in SCD$134,999
K01 · FY2011 · HL · contact PI
PROPRANOLOL AS ANTI-ADHESIVE THERAPY IN SCD$192,550
R21 · FY2010 · HL
Phase 11 Study of Propranolol as Anti-Adhesive Therapy in SCD$130,452
K01 · FY2010 · HL · contact PI
Relationship of Depression to SCD Severity, Health Care Utilization and QoL$135,335
R21 · FY2009 · HS · contact PI
Phase 11 Study of Propranolol as Anti-Adhesive Therapy in SCD$130,491
K01 · FY2009 · HL · contact PI
Relationship of Depression to SCD Severity, Health Care Utilization and QoL$177,141
R21 · FY2008 · HS · contact PI